Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma
2016 · Scientific Reports · 71 citations
https://doi.org/10.1038/srep24185
X
Xiao‐Nan Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
438
Papers
8.6K
Citations
47
h-index
123
i10-index
Xiao‐Nan Li is an academic researcher from Northwestern University. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cancer Research and Treatments & Cancer, Hypoxia, and Metabolism. The author has an h-index of 47, co-authored 373 publications.
ORCID: 0000-0002-6719-3789Papers by this author
worksResearch progress on the pathogenesis of diabetic retinopathy
2023 · BMC Ophthalmology · 61 citations
https://doi.org/10.1186/s12886-023-03118-6
Milk Fat Globule Membrane as a Modulator of Infant Metabolism and Gut Microbiota: A Formula Supplement Narrowing the Metabolic Differences between Breastfed and Formula‐Fed Infants
2020 · Molecular Nutrition & Food Research · 51 citations
https://doi.org/10.1002/mnfr.202000603
Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells
2014 · Acta Neuropathologica · 37 citations
https://doi.org/10.1007/s00401-014-1327-6
Polycomb group gene BMI1 controls invasion of medulloblastoma cells and inhibits BMP-regulated cell adhesion
2014 · Acta Neuropathologica Communications · 37 citations
https://doi.org/10.1186/2051-5960-2-10
Convergence of BMI1 and CHD7 on ERK Signaling in Medulloblastoma
2017 · Cell Reports · 36 citations
https://doi.org/10.1016/j.celrep.2017.11.021
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat